SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-191500
Filing Date
2024-08-01
Accepted
2024-08-01 16:08:53
Documents
13
Period of Report
2024-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d880653d8k.htm   iXBRL 8-K 28197
  Complete submission text file 0001193125-24-191500.txt   151823

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vir-20240731.xsd EX-101.SCH 2835
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20240731_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20240731_pre.xml EX-101.PRE 11252
15 EXTRACTED XBRL INSTANCE DOCUMENT d880653d8k_htm.xml XML 3630
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 241166681
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)